The effects of treatment on lipoprotein subfractions evaluated by polyacrylamide gel electrophoresis in patients with autoimmune hypothyroidism and hyperthyroidism

Lipids in Health and Disease

Research

Zuzana Minarikova¹  Ludovit Gaspar¹  Zuzana Celecová²  Stanislav Oravec³  Peter Kruzliak⁴ 

[1] 2nd Department of Internal Medicine, Faculty of Medicine, University Hospital and Comenius University, Bratislava, Slovak Republic;2nd Department of Internal Medicine, Faculty of Medicine, University Hospital and Comenius University, Bratislava, Slovak Republic;Department of Internal Medicine, Hospital of L. N. Jégé, M.D, Dolný Kubín, Slovakia;2nd Department of Internal Medicine, Faculty of Medicine, University Hospital and Comenius University, Bratislava, Slovak Republic;Krankenanstalten Labor Dr. Dostal, Vienna, Austria;Department of Cardiovascular Diseases, International Clinical Research Center, St. Anne’s University Hospital and Masaryk University, Pekarska 53, 656 91, Brno, Czech Republic;

关键词: Atherogenic dyslipidemia;    Hypothyroidism;    Small dense LDL;    apoB;    Atherogenic index of plasma;   

DOI  :  10.1186/1476-511X-13-158

 received in 2014-07-30, accepted in 2014-10-01,  发布年份 2014

来源: Springer

【 摘 要 】

BackgroundAtherogenic dyslipoproteinemia is one of the most important risk factor for atherosclerotic changes development. Hypothyroidism is one of the most common causes of secondary dyslipidemias which results from reduced LDL clearance and therefore raised levels of LDL and apoB. Association between small dense LDL (sdLDL) presentation and thyroid status has been examinated using polyacrylamide gel electrophoresis for lipoprotein subfractions evaluation.Methods40 patients with diagnosed autoimmune hypothyroidism and 30 patients with autoimmune hyperthyroidism were treated with thyroxine replacement or thyreo-suppressive treatment. In both groups lipid profiles, LDL subractions, apolipoproteins (apoA1, apoB), apoA1/apoB ratio and atherogenic index of plazma (AIP) were examined before treatment and in state of euthyreosis.ResultsThyroxine replacement therapy significantly reduced levels of total cholesterol (TC), LDL, triglycerides (TG) and also decreased levels of sdLDL (8,55±11,671 vs 0,83±1,693mg/dl; p<0,001), apoB and AIP. For estimation of atherogenic lipoprotein profile existence an AIP evaluation seems to be better than apoB measurement because of the more evident relationship with sdLDL (r=0,538; p<0,01). Thyreo-suppressive therapy significantly increased levels of TC, LDL, TG and apoB. The sdLDL was not found in hyperthyroid patients.ConclusionsAtherogenic lipoprotein profile was present in 52.5% of hypothyroid subjects, which is higher prevalence than in normal, age-related population. Substitution treatment leads to an improvement of the lipid levels, TG, apoB, AIP and LDL subclasses. It significantly changed the presentation of sdLDL – we noticed shift to large, less atherogenic LDL particles. Significantly positive correlation between sdLDL and TAG; sdLDL and VLDL alerts to hypertriglyceridemia as a major cardiovascular risk factor.

【 授权许可】

Unknown   
© Minarikova et al.; licensee BioMed Central Ltd. 2014. This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.